Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical SG&A Expenses 2010-2023 | TAK

Takeda Pharmaceutical annual/quarterly sg&a expenses history and growth rate from 2010 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Takeda Pharmaceutical sg&a expenses for the quarter ending December 31, 2023 were $1.819B, a 2.32% decline year-over-year.
  • Takeda Pharmaceutical sg&a expenses for the twelve months ending December 31, 2023 were $7.320B, a 0.55% decline year-over-year.
  • Takeda Pharmaceutical annual sg&a expenses for 2024 were $7.271B, a 1.47% decline from 2023.
  • Takeda Pharmaceutical annual sg&a expenses for 2023 were $7.38B, a 6.45% decline from 2022.
  • Takeda Pharmaceutical annual sg&a expenses for 2022 were $7.889B, a 4.16% decline from 2021.
  
Takeda Pharmaceutical Annual SG&A Expenses
(Millions of US $)
2024 $7,271
2023 $7,380
2022 $7,889
2021 $8,231
2020 $8,876
2019 $6,458
2018 $5,653
2017 $5,757
2016 $5,401
2015 $5,575
2014 $5,562
2013 $11,944
2012 $10,296
2011 $5,372
2010 $4,992
2009 $
Takeda Pharmaceutical Quarterly SG&A Expenses
(Millions of US $)
2023-12-31 $1,819
2023-09-30 $1,745
2023-06-30 $1,811
2023-03-31 $1,944
2022-12-31 $1,862
2022-09-30 $1,791
2022-06-30 $1,782
2022-03-31 $1,925
2021-12-31 $2,033
2021-09-30 $1,929
2021-06-30 $2,001
2021-03-31 $2,179
2020-12-31 $2,137
2020-09-30 $2,033
2020-06-30 $1,882
2020-03-31 $2,330
2019-12-31 $2,293
2019-09-30 $2,076
2019-06-30 $2,177
2018-12-31 $1,370
2018-06-30 $1,334
2017-06-30 $1,313
2016-06-30 $1,348
2015-06-30 $1,326
2015-03-31
2014-12-31 $5,606
2014-09-30
2014-06-30 $1,210
2014-03-31
2013-12-31
2013-09-30
2013-06-30 $1,717
2013-03-31
2012-12-31
2012-09-30
2012-06-30 $1,919
2012-03-31
2011-12-31
2011-09-30
2011-03-31
2010-03-31
2009-09-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $41.839B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.423B 32.29
Chugai Pharmaceutical (CHGCY) Japan $52.640B 23.53
Merck (MKGAF) Germany $23.264B 22.56
Astellas Pharma (ALPMY) Japan $17.156B 27.09
Sandoz Group AG (SDZNY) Switzerland $15.184B 0.00
Neurocrine Biosciences (NBIX) United States $14.320B 39.20
Shionogi (SGIOY) Japan $13.522B 11.75
United Therapeutics (UTHR) United States $12.165B 12.97
Catalent (CTLT) United States $10.021B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.670B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.871B 7.55
Revolution Medicines (RVMD) United States $6.502B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.446B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.690B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.053B 0.00
Summit Therapeutics (SMMT) United States $3.117B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.076B 0.00
Corcept Therapeutics (CORT) United States $2.924B 26.50
PTC Therapeutics (PTCT) United States $2.538B 0.00
Dyne Therapeutics (DYN) United States $2.419B 0.00
Indivior (INDV) United States $2.340B 11.09
Recursion Pharmaceuticals (RXRX) United States $2.210B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.105B 11.97
Catalyst Pharmaceuticals (CPRX) United States $1.948B 18.95
Evotec AG (EVO) Germany $1.860B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.830B 0.00
Ardelyx (ARDX) United States $1.817B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.808B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.590B 27.83
Soleno Therapeutics (SLNO) United States $1.542B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.489B 0.00
Pacira BioSciences (PCRX) United States $1.435B 13.64
Xencor (XNCR) United States $1.420B 0.00
4D Molecular Therapeutics (FDMT) United States $1.310B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.296B 0.00
Cassava Sciences (SAVA) United States $1.109B 0.00
Cronos Group (CRON) Canada $1.108B 0.00
Enliven Therapeutics (ELVN) United States $1.084B 0.00
Collegium Pharmaceutical (COLL) United States $1.062B 6.35
Ironwood Pharmaceuticals (IRWD) United States $1.014B 15.81
Ocular Therapeutix (OCUL) United States $0.956B 0.00
USANA Health Sciences (USNA) United States $0.933B 15.26
ProKidney (PROK) United States $0.930B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.891B 0.00
Relay Therapeutics (RLAY) United States $0.881B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.822B 0.00
Sage Therapeutics (SAGE) United States $0.704B 0.00
Lyell Immunopharma (LYEL) United States $0.699B 0.00
Silence Therapeutics (SLN) United Kingdom $0.688B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.661B 0.00
Exscientia (EXAI) United Kingdom $0.629B 0.00
Savara (SVRA) United States $0.619B 0.00
Harrow (HROW) United States $0.593B 0.00
Altimmune (ALT) United States $0.568B 0.00
Siga Technologies (SIGA) United States $0.541B 6.92
OmniAb (OABI) United States $0.521B 0.00
Korro Bio (KRRO) United States $0.507B 0.00
Bioventus (BVS) United States $0.505B 19.33
KalVista Pharmaceuticals (KALV) United States $0.503B 0.00
Verve Therapeutics (VERV) United States $0.502B 0.00
Heron Therapeutics (HRTX) United States $0.482B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.481B 0.00
Larimar Therapeutics (LRMR) United States $0.471B 0.00
Lexeo Therapeutics (LXEO) United States $0.456B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.452B 0.00
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Tourmaline Bio (TRML) United States $0.386B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.368B 0.00
Organogenesis (ORGO) United States $0.363B 68.50
Nanobiotix S.A (NBTX) France $0.341B 0.00
Fractyl Health (GUTS) United States $0.338B 0.00
Nektar Therapeutics (NKTR) United States $0.322B 0.00
Xeris Biopharma Holdings (XERS) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 18.57
Aquestive Therapeutics (AQST) United States $0.283B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Metagenomi (MGX) United States $0.262B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.257B 0.00
ESSA Pharma (EPIX) Canada $0.253B 0.00
Pyxis Oncology (PYXS) United States $0.244B 0.00
Akebia Therapeutics (AKBA) United States $0.241B 0.00
Eliem Therapeutics (ELYM) United States $0.240B 0.00
Aldeyra Therapeutics (ALDX) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Prelude Therapeutics (PRLD) United States $0.220B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Acrivon Therapeutics (ACRV) United States $0.201B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
CytoDyn (CYDY) United States $0.199B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Century Therapeutics (IPSC) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.192B 234.67
Telomir Pharmaceuticals (TELO) United States $0.183B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.172B 0.00
VAXART, INC (VXRT) United States $0.170B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Incannex Healthcare (IXHL) Australia $0.159B 0.00
Elite Pharmaceuticals (ELTP) United States $0.153B 14.30
Context Therapeutics (CNTX) United States $0.150B 0.00
Cardiol Therapeutics (CRDL) Canada $0.148B 0.00
OptiNose (OPTN) United States $0.142B 0.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
Regulus Therapeutics (RGLS) United States $0.131B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.32
FibroGen (FGEN) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
Vivani Medical (VANI) United States $0.110B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
SCYNEXIS (SCYX) United States $0.105B 1.47
Assertio Holdings (ASRT) United States $0.102B 4.65
Relmada Therapeutics (RLMD) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.096B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Jaguar Animal Health (JAGX) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.071B 0.00
Journey Medical (DERM) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Protara Therapeutics (TARA) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Inotiv (NOTV) United States $0.050B 0.00
Nutriband (NTRB) United States $0.049B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.047B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Lipocine (LPCN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Surrozen (SRZN) United States $0.031B 0.00
JanOne (JAN) United States $0.030B 0.00
DURECT (DRRX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
TherapeuticsMD (TXMD) United States $0.026B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.80
PolyPid (PYPD) Israel $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
CERo Therapeutics Holdings (CERO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Plus Therapeutics (PSTV) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
SHINECO (SISI) China $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.12
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.10